JP2010524930A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524930A5
JP2010524930A5 JP2010504040A JP2010504040A JP2010524930A5 JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5 JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5
Authority
JP
Japan
Prior art keywords
pyrido
pyrimidin
dihydro
benzonitrile
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524930A (ja
JP5498374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004208 external-priority patent/WO2008130481A1/en
Publication of JP2010524930A publication Critical patent/JP2010524930A/ja
Publication of JP2010524930A5 publication Critical patent/JP2010524930A5/ja
Application granted granted Critical
Publication of JP5498374B2 publication Critical patent/JP5498374B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504040A 2007-04-17 2008-03-31 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用 Expired - Fee Related JP5498374B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92510907P 2007-04-17 2007-04-17
US60/925,109 2007-04-17
US1051208P 2008-01-08 2008-01-08
US61/010,512 2008-01-08
PCT/US2008/004208 WO2008130481A1 (en) 2007-04-17 2008-03-31 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2010524930A JP2010524930A (ja) 2010-07-22
JP2010524930A5 true JP2010524930A5 (enExample) 2011-04-07
JP5498374B2 JP5498374B2 (ja) 2014-05-21

Family

ID=39875785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504040A Expired - Fee Related JP5498374B2 (ja) 2007-04-17 2008-03-31 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用

Country Status (12)

Country Link
US (2) US8076345B2 (enExample)
EP (1) EP2139334B1 (enExample)
JP (1) JP5498374B2 (enExample)
CN (1) CN101677569B (enExample)
CA (1) CA2682692A1 (enExample)
CY (1) CY1114382T1 (enExample)
DK (1) DK2139334T3 (enExample)
ES (1) ES2427999T3 (enExample)
HR (1) HRP20130867T1 (enExample)
PL (1) PL2139334T3 (enExample)
PT (1) PT2139334E (enExample)
WO (1) WO2008130481A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5539235B2 (ja) 2008-02-29 2014-07-02 エボテック・アーゲー アミド化合物、組成物およびそれらの使用
WO2010066629A2 (en) * 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
UA112517C2 (uk) 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні
AU2014253493B2 (en) * 2010-07-06 2016-04-14 Novartis Ag Tetrahydro-pyrido-pyrimidine derivatives
JP2014518256A (ja) * 2011-06-27 2014-07-28 ノバルティス アーゲー テトラヒドロ−ピリド−ピリミジン誘導体の固体形態および塩類
PL2790705T3 (pl) 2011-12-15 2018-06-29 Novartis Ag Zastosowanie inhibitorów czynności lub funkcji PI3K
CN103497149A (zh) * 2013-10-08 2014-01-08 南京复兴生物科技有限公司 一种5-氨甲基吡啶衍生物的制备方法
US10183937B2 (en) 2014-12-09 2019-01-22 Bayer Aktiengesellschaft 1,3-thiazol-2-yl substituted benzamides
HUE055290T2 (hu) 2014-12-09 2021-11-29 Bayer Ag 1,3-Tiazol-2-il-csoporttal szubsztituált benzamid-származékok
WO2017049498A1 (zh) * 2015-09-23 2017-03-30 前湾医药科技(深圳)有限公司 一种咪唑并吡啶类化合物与在制备pi3k抑制剂中的应用
US20230096028A1 (en) * 2019-03-01 2023-03-30 Revolution Medicines, Inc. Bicyclic heterocyclyl compounds and uses thereof
BR112021022099A2 (pt) 2019-05-31 2021-12-28 Chiesi Farm Spa Derivados de amino quinazolina como inibidores de p2x3
KR20220016074A (ko) 2019-05-31 2022-02-08 키에시 파르마슈티시 엣스. 피. 에이. P2x3 억제제로서 피리도피리미딘 유도체
TWI793704B (zh) * 2020-08-06 2023-02-21 大陸商北京泰德製藥股份有限公司 Sos1抑制劑、包含其的藥物組合物及其用途
CA3196335A1 (en) 2020-11-27 2022-06-02 Chiesi Farmaceutici S.P.A. Phthalazine derivatives as p2x3 inhibitors
CN116601149A (zh) 2020-11-27 2023-08-15 奇斯药制品公司 作为p2x3抑制剂的氨基喹唑啉衍生物
AU2021386684A1 (en) 2020-11-27 2023-05-25 Chiesi Farmaceutici S.P.A. (aza)quinoline 4-amines derivatives as p2x3 inhibitors
KR20250110929A (ko) 2022-12-02 2025-07-21 뉴모라 테라퓨틱스, 인코포레이티드 신경학적 장애를 치료하는 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3424760A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
DE2502588A1 (de) 1975-01-23 1976-07-29 Troponwerke Dinklage & Co Basisch substituierte derivate des 7-amino-2-chinolons, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA2373510A1 (en) 1999-05-12 2000-11-23 Ortho-Mcneil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
DE60122285D1 (de) * 2000-01-14 2006-09-28 Us Gov Health & Human Serv Methonocarbacycloalkylanaloga von nucleosiden
US6531478B2 (en) 2000-02-24 2003-03-11 Cheryl P. Kordik Amino pyrazole derivatives useful for the treatment of obesity and other disorders
KR20030024799A (ko) 2000-07-20 2003-03-26 뉴로젠 코포레이션 캡사이신 수용체 리간드
BR0116662A (pt) 2001-01-02 2003-09-23 Hoffmann La Roche Derivados de quinazolona como antagonistas receptores alfa 1a/b adrenérgicos
WO2002088079A2 (en) 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
GB0206033D0 (en) 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
AU2003242252A1 (en) 2002-06-07 2003-12-22 Kyowa Hakko Kogyo Co., Ltd. Bicyclic pyrimidine derivatives
GB0225908D0 (en) 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
CA2510471A1 (en) 2002-12-19 2004-07-08 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
TW200530235A (en) * 2003-12-24 2005-09-16 Renovis Inc Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
US7297700B2 (en) * 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
EP1885369B1 (en) * 2005-05-04 2015-09-23 Evotec AG Fused heterocyclic compounds, and compositions and uses thereof
JP5396379B2 (ja) * 2007-04-02 2014-01-22 エボテック・アーゲー ピリド−2−イル縮合複素環式化合物ならびにその組成物および使用
US8546388B2 (en) * 2008-10-24 2013-10-01 Purdue Pharma L.P. Heterocyclic TRPV1 receptor ligands

Similar Documents

Publication Publication Date Title
JP2010524930A5 (enExample)
JP2010523562A5 (enExample)
US20190040025A1 (en) Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application
AU2014222756B2 (en) Inhibitors of histone demethylases
JP2012502986A5 (enExample)
AU2016201584B2 (en) Phosphatidylinositol 3-kinase inhibitors
AU2013234009B2 (en) Heterocyclyl compounds as MEK inhibitors
JP5066175B2 (ja) ヒスタミンh4受容体のモジュレーターとしてのベンゾイミダゾール−2−イルピリミジンおよびピラジン
JP2011514894A5 (enExample)
US8076345B2 (en) 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
JP5204091B2 (ja) 新規なベンジル(ヘテロサイクリックメチル)アミン構造を有するピリミジン化合物及びこれを含有する医薬
EP3475284A1 (en) Pyrrolobenzodiazepines and conjugates thereof
CN103200822A (zh) 2-取代-8-烷基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-腈和其应用
WO2017101884A1 (zh) 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
WO2018133716A1 (zh) 杂环脲类化合物及其药物组合物和应用
TW201107318A (en) Furazanobenzimidazoles
AU2015335783B2 (en) Tricyclic atropisomer compounds
JP2007509043A5 (enExample)
AU2018338098A1 (en) Cyclic iminopyrimidine derivatives as kinase inhibitors
AU2014302550A1 (en) Carbazole carboxamide compounds useful as kinase inhibitors
JP2019510801A5 (enExample)
JP2011526911A (ja) ベンゾイミダゾール−2−イルピリミジン誘導体を製造する方法
JP7338711B2 (ja) Dpアンタゴニスト
JP4272056B2 (ja) アリールピペラジンに連結したテトラヒドロインドロン及びプリン誘導体
JP7691974B2 (ja) アセチル補酵素aシンテターゼ短鎖2(acss2)の小分子阻害剤